Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
1,060.90Prev. Close
1,071.40Volume
3,25,876Total traded value
33.99 CrUpper Circuit
1,251.40Lower Circuit
834.40Fundamentals
| Market Cap | ₹17,074Cr |
| ROE | 8.92% |
| P/E Ratio(TTM) | 37.10 |
| EPS(TTM) | 28.89 |
| P/B Ratio | 2.73 |
| Dividend Yield | 0.47% |
| Industry P/E | 34.97 |
| Book Value | 392.66 |
| Debt to Equity | 0.44 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Jubilant Pharmova
Jubilant Pharmova is a global pharmaceutical company involved in radiopharma, allergy immunotherapy, sterile injectables, generics, and drug discovery businesses. The company's success is driven by its inherent capability to innovate, strengthen its growth levers, and discover new-age sustainable solutions. It operates the second-largest radiopharmacy network in the US, catering to over 1,800 hospitals with 46 pharmacies.;
| Parent Organisation | Jubilant Pharmova Limited |
| Managing Director | Mr. Arjun Bhartia |
| NSE Symbol | JUBLPHARMA |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Top Mutual Funds Invested(4)
| FUND NAME | AUM(%) |
|---|---|
| Bandhan Focused Fund Direct Growth | 3.19% |
| Kotak Contra Fund Direct Growth | 1.32% |
| Bandhan Small Cap Fund Direct Growth | 1.08% |
| Quant Small Cap Fund Direct Plan Growth | 1.05% |
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 67.90 | ||
| Neuland Laboratories | NA (0.00%) | 107.92 | ||
| Acutaas Chemicals | NA (0.00%) | 60.59 | ||
| Aarti Drugs | NA (0.00%) | 24.65 |